Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Atara Biotherapeutics (AT20) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:AT20Atara BiotherapeuticsEUR 5.65EUR 60.23M-6.45-51.29%Moderate BuyUnlock the DE:AT20 analyst price target with TipRanks PremiumDE:AT20Unlock the DE:AT20 top-analyst price target with TipRanks Premium
MGNXMacroGenics$1.97$131.01M-2.5427.92%Moderate BuyUnlock the MGNX analyst price target with TipRanks PremiumDE:AT20 vs MGNXUnlock the MGNX top-analyst price target with TipRanks Premium
ZNTLZentalis Pharmaceuticals$1.36$146.42M-0.780.00%Moderate BuyUnlock the ZNTL analyst price target with TipRanks PremiumDE:AT20 vs ZNTLUnlock the ZNTL top-analyst price target with TipRanks Premium
SRZNSurrozen$31.74$571.47M-0.69145.10%Strong BuyUnlock the SRZN analyst price target with TipRanks PremiumDE:AT20 vs SRZNUnlock the SRZN top-analyst price target with TipRanks Premium
TCRXTScan Therapeutics$0.15$10.23M-0.17-85.05%HoldUnlock the TCRX analyst price target with TipRanks PremiumDE:AT20 vs TCRXUnlock the TCRX top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:AT20Atara Biotherapeutics5.65-5.65-50.00%
MGNXMacroGenics1.970.5538.73%
ZNTLZentalis Pharmaceuticals1.360.032.26%
SRZNSurrozen31.7418.24135.11%
TCRXTScan Therapeutics0.15-0.88-85.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts